Business1 min read

Mayne Pharma shares surge on $407 mln takeover offer from Gedeon Richter

By · Via Investing.com Markets · Published by Everything Blog

In short

The market responded swiftly after Gedeon Richter tabled a buyout proposal valued at $407 million. Equity in Mayne Pharma jumped substantially in the wake of the acquisition approach. The offer represents a significant takeover attempt targeting the pharmaceutical company.

Key points

  • Mayne Pharma is currently evaluating a significant buyout offer from suitor Gedeon Richte…: Mayne Pharma is currently evaluating a significant buyout offer from suitor Gedeon Richter.
  • Investor enthusiasm drove a sharp rally in the target company's publicly traded shares.: Investor enthusiasm drove a sharp rally in the target company's publicly traded shares.
  • The transaction would value the pharmaceutical business at a total of $407 million.: The transaction would value the pharmaceutical business at a total of $407 million.
Business